Literature DB >> 35070799

Molecular signaling pathways in right ventricular impairment of adult patients after tetralogy of Fallot repair.

Kathrin Pollmann1, Sarala Raj Murthi1, Damir Kračun1,2, Thomas Schwarzmayr3, Andreas Petry1,2, Julie Cleuziou4,5, Jürgen Hörer4, Mathieu Klop1,2, Peter Ewert1,6, Agnes Görlach1,2,6, Cordula Maria Wolf1,6.   

Abstract

BACKGROUND: Right ventricular impairment (RVI) secondary to altered hemodynamics contributes to morbidity and mortality in adult patients after tetralogy of Fallot (TOF) repair. The goal of this study was to describe signaling pathways contributing to right ventricular (RV) remodeling by analyzing over lifetime alterations of RV gene expression in affected patients.
METHODS: RV tissue was collected at the time of cardiac surgery in 13 patients with a diagnosis of TOF. RNA was isolated and whole transcriptome sequencing was performed. Gene profiles were compared between a group of 6 adults with signs of RVI undergoing right ventricle to pulmonary artery conduit surgery and a group of 7 infants, undergoing TOF correction. Definition of RVI in adult patients was based on clinical symptoms, evidence of RV hypertrophy, dilation, dysfunction or elevated pressure on echocardiographic, cardiovascular magnetic resonance, or catheterization evaluation.
RESULTS: Median age was 34 years in RVI patients and 5 months in infants. Based on P adjusted value <0.01, RNA sequencing of RV specimens identified a total of 3,010 differentially expressed genes in adult patients with TOF and RVI as compared to infant patients with TOF. Gene Ontology and Kyoto Encyclopedia of Genes databases highlighted pathways involved in cellular metabolism, cell-cell communication, cell cycling and cellular contractility to be dysregulated in adults with corrected TOF and chronic RVI.
CONCLUSIONS: RV transcriptome profiling in adult patients with RVI after TOF repair allows identification of signaling pathways, contributing to pathologic RV remodeling and helps in the discovery of biomarkers for disease progression and of new therapeutic targets. 2021 Cardiovascular Diagnosis and Therapy. All rights reserved.

Entities:  

Keywords:  Right ventricular impairment (RVI); congenital heart disease; molecular signaling pathways; transcriptome profiling

Year:  2021        PMID: 35070799      PMCID: PMC8748492          DOI: 10.21037/cdt-20-894

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  45 in total

Review 1.  Can the cardiomyocyte cell cycle be reprogrammed?

Authors:  Katrina A Bicknell; Carmen H Coxon; Gavin Brooks
Journal:  J Mol Cell Cardiol       Date:  2007-01-24       Impact factor: 5.000

Review 2.  Cardiac myocyte cell cycle control in development, disease, and regeneration.

Authors:  Preeti Ahuja; Patima Sdek; W Robb MacLellan
Journal:  Physiol Rev       Date:  2007-04       Impact factor: 37.312

Review 3.  Microvesicles and exosomes for intracardiac communication.

Authors:  Joost P G Sluijter; Vera Verhage; Janine C Deddens; Frederieke van den Akker; Pieter A Doevendans
Journal:  Cardiovasc Res       Date:  2014-01-30       Impact factor: 10.787

4.  Defining the molecular signatures of human right heart failure.

Authors:  Jordan L Williams; Omer Cavus; Emefah C Loccoh; Sara Adelman; John C Daugherty; Sakima A Smith; Benjamin Canan; Paul M L Janssen; Sara Koenig; Crystal F Kline; Peter J Mohler; Elisa A Bradley
Journal:  Life Sci       Date:  2018-01-31       Impact factor: 5.037

5.  Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration.

Authors:  Tamer M A Mohamed; Yen-Sin Ang; Ethan Radzinsky; Ping Zhou; Yu Huang; Arye Elfenbein; Amy Foley; Sergey Magnitsky; Deepak Srivastava
Journal:  Cell       Date:  2018-03-01       Impact factor: 41.582

6.  Gender differences in molecular remodeling in pressure overload hypertrophy.

Authors:  E O Weinberg; C D Thienelt; S E Katz; J Bartunek; M Tajima; S Rohrbach; P S Douglas; B H Lorell
Journal:  J Am Coll Cardiol       Date:  1999-07       Impact factor: 24.094

7.  Single-Cell Resolution of Temporal Gene Expression during Heart Development.

Authors:  Daniel M DeLaughter; Alexander G Bick; Hiroko Wakimoto; David McKean; Joshua M Gorham; Irfan S Kathiriya; John T Hinson; Jason Homsy; Jesse Gray; William Pu; Benoit G Bruneau; J G Seidman; Christine E Seidman
Journal:  Dev Cell       Date:  2016-11-10       Impact factor: 12.270

8.  Retinoic acid signalling is activated in the postischemic heart and may influence remodelling.

Authors:  Dusan Bilbija; Fred Haugen; Julia Sagave; Anton Baysa; Nasser Bastani; Finn Olav Levy; Allan Sirsjö; Rune Blomhoff; Guro Valen
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

9.  Contemporary predictors of death and sustained ventricular tachycardia in patients with repaired tetralogy of Fallot enrolled in the INDICATOR cohort.

Authors:  Anne Marie Valente; Kimberlee Gauvreau; Gabriele Egidy Assenza; Sonya V Babu-Narayan; Jenna Schreier; Michael A Gatzoulis; Maarten Groenink; Ryo Inuzuka; Philip J Kilner; Zeliha Koyak; Michael J Landzberg; Barbara Mulder; Andrew J Powell; Rachel Wald; Tal Geva
Journal:  Heart       Date:  2013-10-31       Impact factor: 5.994

10.  Changes in contractile protein expression are linked to ventricular stiffness in infants with pulmonary hypertension or right ventricular hypertrophy due to congenital heart disease.

Authors:  Andrew R Bond; Dominga Iacobazzi; Safa Abdul-Ghani; Mohammed Ghorbel; Kate Heesom; Mariangela Wilson; Christopher Gillett; Sarah J George; Massimo Caputo; Saadeh Suleiman; Robert M R Tulloh
Journal:  Open Heart       Date:  2018-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.